A Phase II Study to Determine the Efficacy and Safety of Sivelestat in Subjects With Acute Lung Injury

Birmingham

Phoenix

Tucson

Orange

Sacramento

San Diego

Denver

Englewood

New Haven

Washington D.C.

Bay Pines

Clearwater

Fort Lauderdale

Augusta

Austell

Chicago

Elk Grove Village

Maywood

North Chicago

Indianapolis

Des Moines

Kansas City

Lexington

Louisville

Baton Rouge

Lake Charles

Shreveport

Portland

Baltimore

Silver Spring

Towson

Boston

Detroit

Kalamazoo

St Louis

Camden

Hackensack

Holmdel

Buffalo

Elmhurst

Manhasset

Mineola

New York

Rochester

The Bronx

Greensboro

Winston-Salem

Akron

Cincinnati

Toledo

Portland

Allentown

Hershey

Philadelphia

Pittsburgh

Providence

Sioux Falls

Memphis

Nashville

Houston

Irving

Lubbock

San Antonio

Newport News

Morgantown

Garran

Camperdown

Kingswood

Kogarah

St Leonards

Wentworthville

Southport

Adelaide

Bedford Park

Woodville

Heidelberg

Parkville

Prahran

Fremantle

Perth

Aaist

Antwerp

Arion

Braine-l'Alleud

Bruges

Brussels

Ghent

Liège

Edmonton

Vancouver

Winnipeg

Halifax

Hamilton

Toronto

Windsor

Montreal

Sherbrooke

Christchurch

Auckland

Hastings

Wellington

Badajoz

Manresa

Sabadell

Getafe

Madrid

El Palmar

Murcia

Palma de Mallorca

Barcelona